FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

August 12, 2024 | The Conversation

ASU drug researcher Benjamin Y. Fong writes about what the FDA’s recent MDMA ruling entails and what it means for the future of psychedelic medications.

Read on theconversation.com